Title : Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy.

Pub. Date : 2021 Mar 1

PMID : 33310889






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: OTX015 and carfilzomib combination therapy is likely to be translated into the first clinical trial of a targeted therapy in TERT-rearranged neuroblastoma patients. carfilzomib telomerase reverse transcriptase Homo sapiens